Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.65 USD | -5.31% | -5.67% | +28.54% |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 69.36M 94.8M |
---|---|---|---|---|---|
Net income 2024 * | -81M -111M | Net income 2025 * | -89M -122M | EV / Sales 2024 * | - |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.85
x | P/E ratio 2025 * |
-0.8
x | Employees | 65 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 66.9% |
Latest transcript on Assembly Biosciences, Inc.
1 day | -5.31% | ||
1 week | -5.67% | ||
Current month | -4.89% | ||
1 month | -3.14% | ||
3 months | +17.12% | ||
6 months | +29.47% | ||
Current year | +28.54% |
Managers | Title | Age | Since |
---|---|---|---|
Jason Okazaki
CEO | Chief Executive Officer | 48 | 20-03-29 |
Anuj Gaggar
CTO | Chief Tech/Sci/R&D Officer | - | 11-07 |
William Delaney
CTO | Chief Tech/Sci/R&D Officer | 52 | 20-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Susan Mahony
BRD | Director/Board Member | 60 | 17-12-13 |
Gina Consylman
BRD | Director/Board Member | 52 | 20-10-19 |
William Ringo
CHM | Chairman | 78 | 14-06-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 12.65 | -5.31% | 29,550 |
24-04-25 | 13.36 | -0.89% | 6,103 |
24-04-24 | 13.48 | +1.58% | 5,652 |
24-04-23 | 13.27 | +0.38% | 13,932 |
24-04-22 | 13.22 | -1.42% | 7,405 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+28.54% | 69.36M | |
+5.31% | 70.44B | |
+10.97% | 8.94B | |
-16.83% | 4.75B | |
+43.48% | 4.5B | |
+3.20% | 3.85B | |
+18.82% | 2.38B | |
-21.36% | 2.34B | |
-29.67% | 2.2B | |
+8.38% | 1.96B |
- Stock Market
- Equities
- ASMB Stock